EGA Vision 2015 | Medicines for Europe

To view the full report, please click here.

IQVIA - Assessing the Biosimilar Void 30 October 2023 While biosimilar competition in Europe has played a vital role…
Positioning Statements on Physician-led Switching for… 1 October 2021 Positioning statements on physician-led switching for biosimilar medicines (October 2021)…
Review of the SPC Manufacturing Waiver: a First Industry… 13 June 2023 The Supplementary Protection Certificate (SPC) is a sui generis protection…
2022 Health at a Glance Report highlights the need to… 5 December 2022 Over the last two years, major crises have had dramatic…